Skip to main content
logo
Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.04
+0.03 (0.43%)
Aug 3, 2026, 4:00 PM EDT - Market closed

Aura Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Market Cap
777429347389389294411444375389437343470351397531415643496-
Market Cap Growth (YoY)
85.81%45.82%-15.68%-12.24%3.66%-24.26%-6.01%29.38%-20.31%10.78%10.25%-35.39%13.42%-45.43%-20.04%-----
Enterprise Value
678.77331.42219.69245.14229.37184.77278.66288.24206.47205.06230.65213.94328.77197.9228.65440.17293.26510.33347.930
Last Close Price
7.046.695.456.186.265.868.228.917.567.858.868.9712.359.2810.5018.1214.1722.0016.98-

Price Ratios

Fiscal Quarter
CurrentQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
---------------0.270.361.88--
PB Ratio
4.214.002.532.482.232.302.702.541.961.861.942.262.831.952.034.613.214.563.26-
P/TBV Ratio
4.244.032.402.211.862.282.692.521.841.641.552.272.691.751.614.222.151.930.57-

Financial Efficiency

Fiscal Quarter
CurrentQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Debt / Equity Ratio
0.130.130.100.090.090.120.100.090.090.080.070.110.100.100.090.160.000.000.000.01
Net Debt / Equity Ratio
-0.91-0.91-0.93-0.92-0.91-0.86-0.87-0.89-0.88-0.88-0.91-0.85-0.85-0.85-0.86-0.79-0.94-0.94-0.970.62
Net Debt / EBITDA Ratio
0.830.831.141.281.481.081.391.691.892.122.471.681.962.332.841.702.633.214.301.30
Net Debt / FCF Ratio
1.071.071.491.621.891.371.632.082.262.533.201.982.342.713.021.802.502.944.293.16
Quick Ratio
6.876.877.858.6011.9410.5210.1311.8517.7720.9918.3013.6818.2121.4018.0611.1921.0126.6420.2714.03
Current Ratio
7.097.098.159.0412.3911.0610.7712.4718.5421.9718.7614.1318.6922.0918.8111.6321.9727.9020.9014.31
Return on Equity (ROE)
-92.06%-92.06%-73.52%-68.99%-62.08%-67.66%-46.01%-41.55%-38.67%-36.19%-36.26%-40.79%-37.69%-33.73%-33.78%-40.27%-33.24%-28.74%-41.07%-121.79%
Return on Assets (ROA)
-77.18%-77.18%-64.03%-60.79%-56.11%-60.81%-43.87%-40.33%-38.09%-35.77%-35.42%-38.55%-35.23%-31.13%-31.41%-35.83%-31.96%-27.50%-38.71%-111.92%
Return on Invested Capital (ROIC)
-1212.20%-1212.20%-996.96%-809.27%-641.34%-539.85%-492.01%-437.42%-373.25%-394.10%-402.98%-326.36%-281.10%-243.35%-230.86%-336.80%-579.26%-655.17%-903.04%-2428.86%
Return on Capital Employed (ROCE)
-87.22%-87.22%-70.80%-66.92%-60.87%-66.17%-46.85%-42.96%-40.11%-37.54%-37.26%-40.71%-36.94%-32.54%-32.93%-38.00%-33.45%-28.65%-40.96%-121.03%

Yields

Fiscal Quarter
CurrentQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Earnings Yield
---------------372.74%280.52%53.09%--
Buyback Yield / Dilution
-29.81%-29.72%-21.52%-13.33%-11.58%-14.20%-25.32%-28.50%-28.48%-28.01%-32.34%-43.63%-85.15%-175.64%-480.18%-6351.84%-4806.19%-2739.37%-1305.21%-9.24%
Total Shareholder Return
-29.81%-29.72%-21.52%-13.33%-11.58%-14.20%-25.32%-28.50%-28.48%-28.01%-32.34%-43.63%-85.15%-175.64%-480.18%-6351.84%-4806.19%-2739.37%-1305.21%-9.24%
SEC Filings: 10-K · 10-Q